** Shares of China's biopharmaceuticals products developer Zai Lab Ltd 9688.HK jump 17.1% to HK$32.5, their highest since March 2023, and on course for the second session of gains
** Stock set for the biggest one-day jump since May 9, 2024; second-biggest gainer on healthcare index .HSCIH, which is trading up 1.4%
** Zai Lab, with current market capitalisation of HK$34.26 bln ($4.41 bln), said its 2024 net product revenue increased 49% y/y to $397.6 mln, while R&D expenses decreased 12% y/y to $234.5 mln and net loss reduced 23% y/y to $257.1 mln
** Hang Seng Commerce & Industry Index .HSNC slips 0.7%, Hang Seng Index .HSI eases 0.6%
** Stock up 49% YTD
($1 = 7.7766 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。